Microbot Medical Inc. has scheduled its 2026 Annual Meeting of Shareholders for December 14, 2026. This meeting will be crucial for shareholders as they will vote on several key matters, including the election of two Class II directors and an amendment to the company's performance award plan.

The meeting will take place at the offices of Nixon Peabody LLP in Boston, Massachusetts, at 9:00 A.M. Eastern Time. Shareholders are encouraged to participate, as their votes will shape the future direction of the company.

Microbot Medical, which specializes in surgical and medical instruments and apparatus, aims to enhance shareholder engagement through this annual meeting. The company is also seeking approval for a non-binding advisory resolution on executive compensation and the ratification of its independent registered public accounting firm.

As part of the agenda, shareholders will consider increasing the number of authorized shares for the 2020 Omnibus Performance Award Plan by 1,000,000 shares. This move is intended to support the company’s long-term growth and incentivize key personnel.

Microbot Medical's commitment to transparency and shareholder participation reflects broader trends in the surgical and medical instruments industry, where governance practices are increasingly scrutinized. The outcome of this meeting could influence how similar companies approach shareholder relations and governance in the future.

The record date for determining shareholders entitled to vote at the meeting is set for October 15, 2026. Shareholders are reminded to return their proxy cards to ensure their votes are counted, even if they cannot attend the meeting in person.

Details were not available in the SEC filing regarding any further actions following the meeting.